… to evaluate the real-world effectiveness of Azvudine versus nirmatrelvir–ritonavir in hospitalized
patients with COVID-19. To our knowledge, this is the first real-world study exploring the …

… Using a retrospective cohort study design, we aimed to evaluate the effectiveness of
molnupiravir and nirmatrelvir/ritonavir in patients with SARS-CoV-2 who were highly vulnerable. …

… To the best of our knowledge, this is the first real-world study to explore the inpatient use of
… study to examine the effectiveness of molnupiravir or nirmatrelvir–ritonavir in patients with …

… real-world evidence of the effectiveness of the UK deployment approach is urgently needed.
… sought to compare the effectiveness of sotrovimab, molnupiravir, and nirmatrelvir-ritonavir in …

… users, 890 nirmatrelvir/ritonavir users and 2,746 control patients not initially requiring oxygen
therapy at baseline after propensity-score matching. Oral antiviral use was associated with …

… Guidelines prioritise nirmatrelvir plus ritonavir use over molnupiravir in … the nirmatrelvir
plus ritonavir be accessible and clinically appropriate. This study shows real-world effectiveness …

… [12], additional studies are needed to evaluate real-world effectiveness. We present real-world
data on the effectiveness of nirmatrelvir/ritonavir amongst community-dwelling older …

… of 300 mg nirmatrelvir plus 100 mg ritonavir orally twice daily for … to 150 mg nirmatrelvir plus
100 mg ritonavir twice daily in … Moreover, ritonavir-boosted nirmatrelvir is available through …

… Objectives The aim of this analysis was to describe nirmatrelvir/ritonavir real-world effectiveness
in preventing hospitalization among high-risk US COVID-19 patients during SARS-CoV-…

… Nirmatrelvir/ritonavir has shown to reduce COVID-19 hospitalization and death before …
real-world evidence studies are needed. This study aimed to assess whether nirmatrelvir/ritonavir …